FDA Approves Expanded Indication for Mavyret for Acute HCV

The FDA expanded the indication for Mavyret to treat adults and pediatric patients 36 months of age and older with ...

JULY 2, 2025

Seladelpar Found Safe and Effective For Patients With PBC and Cirrhosis

The newly approved drug seladelpar was found to be safe and effective in treating patients with both PBC and ...

MAY 15, 2025

Nutritional Wellness to Prevent Worsening of Liver Disease

Matthew Kappus, MD, has a lofty goal: to elevate nutritional wellness in patients with liver disease and advanced ...

APRIL 4, 2025

Expanded Study Shows App Reduces Readmissions for Cirrhosis Patients

A patient- and caregiver-targeted app reduced avoidable hospital readmissions in cirrhosis patients compared with ...

MARCH 18, 2025

Cirrhosis Patients Face Higher Bleeding Risk After Colorectal EMR

Patients with cirrhosis undergoing EMR for colorectal polyps face a higher risk for post-procedural bleeding than ...

DECEMBER 31, 2024

FDA Issues Serious Liver Injury Warning for Obeticholic Acid

The FDA has issued a warning of serious liver injury for patients taking obeticholic acid for primary biliary ...

DECEMBER 16, 2024

Simple Exercise Could Benefit Patients With End-Stage Liver Disease

A prehabilitation program for liver transplantation can help improve frailty metrics in patients with end-stage ...

NOVEMBER 5, 2024

Expert Picks From EASL 2024

Ashwani K. Singal, MD, MS, highlights four abstracts from EASL Congress 2024.

OCTOBER 30, 2024

FDA Adds Warning of Serious Liver Injury to Menopause Drug

The FDA has added a warning of a rare occurrence of serious liver injury in patients taking the drug fezolinetant ...

OCTOBER 8, 2024

Early Liver Fibrosis Detection Called an Urgent Unmet Need

There is a great need to create systems and processes to diagnose cirrhosis at a much earlier stage, according to ...

MAY 23, 2024

Study Identifies Predictors of HRS-AKI

Researchers have identified certain characteristics that put patients with cirrhosis more at risk to develop ...

FEBRUARY 19, 2024

Real-World Data Used to Describe MASH Natural History

A longitudinal study of U.S. adults with metabolic dysfunction–associated steatohepatitis elucidates rates of ...

DECEMBER 14, 2023